iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
NASHUA, N.H., Nov. 28, 2023 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader in innovative cancer-detection solutions, today announced that key artificial intelligence (AI) powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s new MyBreastAI Suite* offering.
Related news for (ICAD)
- iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)
- 24/7 Market News Snapshot 16 April, 2025 – Icad Inc (NASDAQ:ICAD)
- MoBot’s Stock Market Highlights – 04/16/25 06:00 AM
- MoBot alert highlights: NASDAQ: BLMZ, NASDAQ: LRHC, NASDAQ: ICAD, NASDAQ: OMEX, NASDAQ: TGL (04/16/25 05:00 AM)
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/16/25 04:00 AM